Forecasting Tunisian type 2 diabetes prevalence to 2027: Validation of a simple model Biostatistics and methods

BMC Public Health

Volumn 15, Issue 1, 2015, Pages

  Saidi, Olfa ^a   O'Flaherty, Martin ^b   Mansour, Nadia Ben ^a   Aissi, Wafa ^a   Lassoued, Olfa ^a   Capewell, Simon ^b   Critchley, Julia A ^c   Malouche, Dhafer ^a   Romdhane, Habiba Ben ^a  

^a UNIVERSITY OF TUNIS EL MANAR   (Tunisia)

^b UNIVERSITY OF LIVERPOOL   (United Kingdom)

^c ST GEORGE S HOSPITAL   (United Kingdom)

Author keywords

Demographic changes; Modeling; Obesity trends; Projection; Smoking trends; Target strategies; Tunisia; Type 2 diabetes prevalence

Indexed keywords

ADULT; AGED; DIABETES MELLITUS, TYPE 2; FEMALE; FORECASTING; HUMAN; MALE; MIDDLE AGED; OBESITY; PREVALENCE; PROBABILITY; PUBLIC HEALTH; RISK FACTOR; SMOKING; THEORETICAL MODEL; TUNISIA; YOUNG ADULT;

ADULT; AGED; DIABETES MELLITUS, TYPE 2; FEMALE; FORECASTING; HUMANS; MALE; MARKOV CHAINS; MIDDLE AGED; MODELS, THEORETICAL; OBESITY; PREVALENCE; PUBLIC HEALTH; RISK FACTORS; SMOKING; TUNISIA; YOUNG ADULT;

EID: 84938994060     PISSN: None     EISSN: 14712458     Source Type: Journal    
DOI: 10.1186/s12889-015-1416-z     Document Type: Article

References (46)

1. Gaziono TA, Bitton A, Anoud S, Abrahms-Gessel S, Murphy A. Growing epidemic of coronary heart disease in low-and middle income countries. CurrProbl Cordial. 2010;35:72-115.
2. Guariguata L, Whiting DR, Hambleton I, Beagley J, Linnenkamp U, Shaw JE. Global estimates of diabetes prevalence for 2013 and projections for 2035. Diabetes Res Clin Pract. 2014;103(2):137-49. doi: 10.1016/j.diabres.2013.11.002, Epub 2013 Dec 1.
3. Barnett A H, Kumar S. Obesity and diabetes, Second Edition. http://onlinelibrary.wiley.com/doi/10.1002/9780470741474.fmatter/pdf. Accessed on 27 January 2015.
4. Mokdad AH, Ford ES, Bowman BA, Dietz WH, Vinicor F, Bales VS, et al. Prevalence of obesity, diabetes, and obesity-related health risk factors. JAMA. 2003;289:76-9.
5. Chan JM, Rimm EB, Colditz GA, Stampfer MJ, Willett WC. Obesity, fat distribution, and weight gain as risk factors for clinical diabetes in men. Diabetes Care. 1994;17:961-9.
6. Chan JM, Rimm EB, Colditz GA, Stampfer MJ, Willett WC. Weight gain as a risk factor for clinical diabetes mellitus in women. Diabetes Care. 1994;17:961-9.
7. James PT, Leach R, Kalamara E, Shayeghi M. The worldwide obesity epidemic. Obes Res. 2001;9:228-33.
8. Willi C, Bodenmann P, Ghali WA, Faris PD, Cornuz J. Active smoking and the risk of type 2 diabetes.A systematic review and meta-analysis. JAMA. 2007;298(22):2654-64.
9. Facchini FS, Hollenbeck CB, Jeppesen J, Chen YD, Reaven GM. Insulin resistance and cigarette smoking. Lancet. 1992;339(8802):1128-30.
10. Schwartz GG, Il'yasova D, Ivanova A. Urinary cadmium, impaired fasting glucose, and diabetes in the NHANES III. Diabetes Care. 2003;26(2):468-70.
11. Eliasson M, Asplund K, Evrin PE, Lundblad D, 1, 1. Relationship of cigarette smoking and snuff dipping to plasma fibrinogen, fibrinolytic variables and serum insulin: the northern Sweden MONICA study. Atherosclerosis. 1995;113:41-53.
12. Godsland IF, Wynn V, Walton C, Stevenson JC. Insulin resistance and cigarette smoking. Lancet. 1992;339(8809):1619-20.
13. Hossain P, Kawar B, El Nahas M. Obesity and diabetes in the developing world: a growing challenge. N Engl J Med. 2007;356:213-5.
14. O'Flaherty M, Critchley J, Wild S, Unwin N, Capewell S. Project ftM: 018 Forecasting diabetes prevalence using a simple model: England and Wales 1993-2006. J Epidemiol Commun Health. 2010, 64. http://jech.bmj.com/content/64/Suppl-1/A7.2.abstract. Accessed on 27 January 2015.
15. Maziak W, Critchley J, Zaman S, Unwin N, Capewell S, Bennett K, Unal B, Husseini A, Romdhane HB, Phillimore P: Mediterranean studies of cardiovascular disease and hyperglycemia: analytical modeling of population socio-economic transitions (MedCHAMPS)-rationale and methods. Int J Public Health 2012. doi:10.1007/s00038-012-0423-4. http://research.ncl.ac.uk/media/sites/researchwebsites/medchamps/Maziak%20et%20al%20IJPH-October2012.pdf. Accessed on 27 January 2015.
16. Al-Quwaidhi AJ, Pearce MS, Sobngwi E, Critchley JA, O'Flaherty M. Comparison of type 2 diabetes prevalence estimates in Saudi Arabia from a validated Markov model against the international diabetes federation and other modelling studies. Diabetes Res Clin Practice. 2014;1 0 3:4 9 6-5 0 3.
17. Abu-Rmeileh MEN, Husseini A, Capewell S, O'Flaherty M. Preventing type 2 diabetes among Palestinians: comparing five future policy scenarios. BMJ Open. 2014;3:e003558. 10.1136/ bmjopen-2013-003558.
18. Al Ali R, Mzayek F, Rastam S, Fouad MF, O'Flaherty M, Capewell S, et al. Forecasting future prevalence of type 2 diabetes mellitus in Syria. BMC Public Health. 2013;13:507.
19. Sözmen K, Unal B, Capewell S, Critchley J, O'Flaherty M. Estimating diabetes prevalence in Turkey in 2025 with and without possible interventions to reduce obesity and smoking prevalence, using a modelling approach. Int J Public Health. 2015 Jan;60 Suppl 1:13-21. doi: 10.1007/s00038-014-0622-2. Epub 2014 Dec. http://www.ncbi.nlm.nih.gov/pubmed/25471076. Accessed on 25 January 2015.
20. Barendregt JJ, Van Oortmarssen GJ, Vos T, Murray CJ. A generic model for the assessment of disease epidemiology: the computational basis of DisMod II. Popul Health Metrics. 2003;1(1):4.
21. World Health Organization: Health statistics and health information systems. Global Burden of Disease (GBD); 2012. http://www.who.int/healthinfo/global-burden-disease/tools-software/en/. Accessed on 25 January 2015
22. Barendregt JJ, Baan CA, Bonneux L. An indirect estimate of the incidence of non-insulin-dependent diabetes mellitus. Epidemiology. 2000;11(3):274-9.
23. Muggeo M, Verlato G, Bonora E, et al. The Verona diabetes study: a population-based survey on known diabetes mellitus prevalence and 5-year all-cause mortality. Diabetologia. 1995;38(3):318-25.
24. National Institute of Statistics, Tunisia. Yearly Statistics Report: Edition N°40; 1997.
25. National Institute of Statistics, Tunisia. Yearly Statistics Report: N°52; 2009. http://www.ins.nat.tn/publication/Anunaire-2009.pdf. Accessed on 25 January 2015.
26. Bouguerra R, Alberti H, Salem LB, Rayana CB, Atti JE, Gaigi S, et al. The global diabetes pandemic: the Tunisian experience. Eur J ClinNutr. 2007;61(2):160-5.
27. Institut national de nutrition et de technologie alimentaire. Evolution de l'état nutritionnel de la population tunisienne. Enquête nationale 1996-1997. http://www.institutdenutrition.rns.tn/images/rapenq/6adultes.pdf. Accessed on 25 January 2015.
28. Institut National de Santé Publique. Epidémiologie des broncho-pneumopathies chroniques chez l'adulte. Résultats de l'enquête nationale menée en 1996-1997; Publications de l'Institut National de Santé Publique N°2. 1999.
29. Cardiovascular epidemiology and prevention research laboratory. Epidemiological transition and health impact in North Africa in 2005. TAHINA Project Final Report. Tunisia Edition 2006.
30. Romdhane HB, Ali SB, Aissi W, Traissac P, Aounallah-Skhiri H, Bougatef S, et al. Prevalence of diabetes in Northern African countries: the case of Tunisia. BMC Public Health. 2014;14:86. doi:10.1186/1471-2458-14-86.
31. Flegal KM, Carroll MD, Kit BK, Ogden CL. Prevalence of obesity and trends in the distribution of body mass index among US adults, 1999-2010. JAMA J Am Med Assoc. 2012;307(5):491-7.
32. Public Health England. Adult obesity and type 2 diabetes. April 2014. http://www.noo.org.uk/securefiles/150128-0939//Adult-obesity-and-type-2-diabetes-20140730.pdf. Accessed on 25 January 2015.
33. Direction Des Soins De Santé De Base. Le programme national de lutte anti tabagique: Réalités et perspectives. Tunis; 2009
34. Institut National de Nutrition et de Technologie Alimentaire. Stratégie Nationale de Prévention et de Lutte contre l'Obésité. Tunis; 2010
35. Briggs A. Economics notes: handling uncertainty in economic evaluation. BMJ. 1999;319:120.
36. International Diabetes Federation. Diabetes Atlas. 5th ed. Brussels, Belgium: International Diabetes Federation; 2011.
37. Beltaïfa L, Traissac P, El Ati J, Lefèvre P, Ben Romdhane H, Delpeuch F. Prevalence of obesity and associated socioeconomic factors among Tunisian women from different living environments. Obes Rev. 2009;10(2):145-53.
38. Elasmi M, Feki M, Sanhaji H, Jemaa R, HajTaeib S, Omar S, et al. Prevalence of conventional cardiovascular risk factors in the Great Tunis population. Rev Epidemiol Sante Publique. 2009;57(2):87-92.
39. Aounallah-Skhiri H, Ben Romdhane H, Traissac P, Eymard-Duvernay S, Delpeuch F, Achour N, et al. Nutritional status of Tunisian adolescents: associated gender, environmental and socio-economic factors. Public Health Nutr. 2008;11(12):1306-17.
40. Le tabac en Tunisie. Association Tunisienne de Lutte Contre le Cancer 2008.
41. Sicree R, Shaw J. Type 2 diabetes: an epidemic or not, and why it is happening, Diabetes metabolic syndrome. Clin Res Rev. 2007;1(2):75-81.
42. Alberti H, Boudrigua N, Nabli M. "Dammsokker": factors associated with the quality of care of patients with diabetes: a study in primary in Unisia. Diabetes Care. 2007;30(8):2013-8.
43. Alberti KG, Zimmet P, Shaw J. International DiabetesFederation: a consensus on type 2 diabetesprevention. Diabet Med. 2007;24(5):451-63.
44. Saaristo T, Peltonen M, Keinänen-Kiukaanniemi S, Vanhala M, Saltevo J, Niskanen L, et al. National type 2 diabetes prevention programme in Finland: FIN-D2D. Int J Circumpolar Health. 2007;66(2):101-12.
45. Spollett RG. Diabetes in Finland: what can happen when a country takes diabetes seriously. Diabetes Spectrum. 2009;22(3):188-90.
46. World Health Organization. Targets to monitor progress in reducing the burden of noncommunicable diseases. 2011.